Download PDF
Am J Perinatol 2024; 41(S 01): e2727-e2734
DOI: 10.1055/a-2149-8810
Original Article

Nationwide Analysis of the Outcomes and Mortality of Hospitalized Infants with Concomitant Diagnosis of COVID-19

Parvathy Krishnan 
1   Department of Neonatal-Perinatal Medicine, Westchester Medical Center and New York Medical College, Valhalla, New York
,
Aaqib Malik
2   Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, New York
,
Ameesh Isath
2   Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, New York
,
Dhrubajyoti Bandyopadhyay
2   Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, New York
,
Akshay Goel
2   Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, New York
,
Lance Parton
1   Department of Neonatal-Perinatal Medicine, Westchester Medical Center and New York Medical College, Valhalla, New York
,
Praveen Chandrasekharan
3   Department of Neonatal-Perinatal Medicine, University at Buffalo, Kaleida Health, UBMD Pediatrics, Buffalo, New York
,
Meenakshi Singh
1   Department of Neonatal-Perinatal Medicine, Westchester Medical Center and New York Medical College, Valhalla, New York
› Author Affiliations Funding P.C. is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; grant no.: R01HD104909).
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective Coronavirus disease 2019 (COVID-19) generally causes milder illness in the pediatric population. However, infants represent a higher-risk population with evolving symptomatology and severity. There is a paucity of large population-based data on the impact of COVID-19 on hospitalized infants.

Study Design In this large cohort study, the National Inpatient Sample database was queried for all infant hospital admissions between January and December 2020 in the United States, with and without a diagnosis of COVID-19 based on ICD-10-CM U07. The mortality and morbidity of infants with and without COVID-19 were evaluated. Parent-reported race and outcomes were also analyzed.

Results A weighted total of 3,754,236 infants who were hospitalized were identified, of which 4,265 patients (0.11%) had a concomitant diagnosis of COVID-19. Infants with COVID-19 had similar mortality and extracorporeal membrane oxygenation utilization. Infants with concomitant COVID-19 had a higher rate of respiratory failure, congestive heart failure, acute kidney injury, and coagulopathy. Compared with Caucasian infants and Asian infants, Hispanic and African American infants were more likely to have COVID-19 hospital admissions than hospitalizations without COVID-19 diagnosis. Patients with lower median household income represented the majority of the COVID-19 hospitalization. The infants with COVID-19 were more likely to have Medicaid or Medicare insurance and less likely to have private insurance.

Conclusion In this large cohort of hospitalized infants with COVID-19, the infection was associated with complications, including respiratory failure and endotracheal intubations but not associated with a higher risk for mortality. Infants from racial minorities and lower socioeconomic strata carry the highest burden of COVID-19 infection.

Key Points

  • Infants with COVID-19 represent a higher-risk group with evolving symptomatology and severity.

  • Infants with COVID-19 had similar mortality rates and extracorporeal membrane oxygenation utilization as those without COVID-19.

  • Racial minorities and lower socioeconomic strata carry the highest burden of COVID-19 infection.

Keywords

COVID-19 - infant outcomes - infant hospital admissions

Summary

This large database analysis explores the outcomes of hospitalized infants with COVID-19 as well as the racial and socioeconomic disparities in the disease burden.


What's Known on This Subject

Infants with COVID-19 represent a vulnerable population with added comorbidities owing to prematurity and respiratory illnesses. The sample size and narrow geographic location limit current data regarding the incidence and impact of COVID-19 in infants.


What This Study Adds

Infants with COVID-19 are at risk for complications such as respiratory failure, heart failure, AKI, and coagulopathy. Infants with BPD were at increased risk for COVID-19 hospitalizations. Infants belonging to ethnic minorities carry a higher burden of COVID-19.


Authors' Contributions

P.K. conceptualized and designed the data collection, drafted the initial manuscript, and critically reviewed and revised the manuscript. A.M. and A.I. conceptualized and designed the study, collected the data, performed the initial analysis, and critically reviewed and revised the manuscript. D.B. and A.G. conceptualized and designed the study, coordinated, and supervised the data collection, and critically reviewed and revised the manuscript. L.P., P.C., and M.S. coordinated and supervised the data collection and critically reviewed and revised the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.


Supplementary Material



Publication History

Received: 16 March 2023

Accepted: 04 August 2023

Accepted Manuscript online:
07 August 2023

Article published online:
08 September 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 De Rose DU, Piersigilli F, Ronchetti MP. et al; Study Group of Neonatal Infectious Diseases of The Italian Society of Neonatology (SIN). Novel coronavirus disease (COVID-19) in newborns and infants: what we know so far. Ital J Pediatr 2020; 46 (01) 56
    CrossrefPubMedGoogle Scholar
  • 2 Children and COVID-19. State-level data report 2022. Accessed August 08, 2022 at: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/
    PubMedGoogle Scholar
  • 3 Allotey J, Chatterjee S, Kew T. et al; PregCOV-19 Living Systematic Review Consortium. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ 2022; 376: e067696
    CrossrefPubMedGoogle Scholar
  • 4 Blumberg DA, Underwood MA, Hedriana HL, Lakshminrusimha S. Vertical Transmission of SARS-CoV-2: what is the optimal definition?. Am J Perinatol 2020; 37 (08) 769-772
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Kotlyar AM, Grechukhina O, Chen A. et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224 (01) 35-53.e3
    CrossrefPubMedGoogle Scholar
  • 6 Rawat M, Chandrasekharan P, Hicar MD, Lakshminrusimha S. COVID-19 in newborns and infants-low risk of severe disease: silver lining or dark cloud?. Am J Perinatol 2020; 37 (08) 845-849
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Pique-Regi R, Romero R, Tarca AL. et al. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?. eLife 2020; 9: 9
    CrossrefPubMedGoogle Scholar
  • 8 Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020; 46 (04) 586-590
    CrossrefPubMedGoogle Scholar
  • 9 Muus C, Luecken MD, Eraslan G. et al; NHLBI LungMap Consortium, Human Cell Atlas Lung Biological Network. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat Med 2021; 27 (03) 546-559
    CrossrefPubMedGoogle Scholar
  • 10 Patil UP, Krishnan P, Abudinen-Vasquez S, Maru S, Noble L. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive newborns of COVID-19 mothers after dyad-care: a case series. Cureus 2021; 13 (01) e12528
    PubMedGoogle Scholar
  • 11 Patil UP, Maru S, Krishnan P. et al. Newborns of COVID-19 mothers: short-term outcomes of colocating and breastfeeding from the pandemic's epicenter. J Perinatol 2020; 40 (10) 1455-1458
    CrossrefPubMedGoogle Scholar
  • 12 Smith V, Seo D, Warty R. et al. Maternal and neonatal outcomes associated with COVID-19 infection: a systematic review. PLoS One 2020; 15 (06) e0234187
    CrossrefPubMedGoogle Scholar
  • 13 Villar J, Ariff S, Gunier RB. et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr 2021; 175 (08) 817-826
    CrossrefPubMedGoogle Scholar
  • 14 Hudak ML, Flannery DD, Barnette K. et al; AMERICAN ACADEMY OF PEDIATRICS NPC-19 REGISTRY INVESTIGATORS. Maternal and newborn hospital outcomes of perinatal SARS-CoV-2 infection: a national registry. Pediatrics 2023; 151 (02) e2022059595
    CrossrefPubMedGoogle Scholar
  • 15 Zeng LK, Zhu HP, Xiao TT. et al. Short-term developmental outcomes in neonates born to mothers with COVID-19 from Wuhan, China. World J Pediatr 2021; 17 (03) 253-262
    CrossrefPubMedGoogle Scholar
  • 16 Lim KH, Soong FSJ, Low YF, Goh XL, Amin Z, Ng YPM. Clinical features and outcomes of neonatal COVID-19: a systematic review. J Clin Virol 2021; 139: 104819
    CrossrefPubMedGoogle Scholar
  • 17 Trevisanuto D, Cavallin F, Cavicchiolo ME, Borellini M, Calgaro S, Baraldi E. Coronavirus infection in neonates: a systematic review. Arch Dis Child Fetal Neonatal Ed 2021; 106 (03) 330-335
    CrossrefPubMedGoogle Scholar
  • 18 Hajra A, Malik A, Bandyopadhyay D. et al. Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: a nationwide analysis. Prog Cardiovasc Dis 2023; 76: 25-30
    CrossrefPubMedGoogle Scholar
  • 19 Kadri SS, Gundrum J, Warner S. et al. Uptake and accuracy of the diagnosis code for COVID-19 among US hospitalizations. JAMA 2020; 324 (24) 2553-2554
    CrossrefPubMedGoogle Scholar
  • 20 Isath A, Malik AH, Goel A, Gupta R, Shrivastav R, Bandyopadhyay D. Nationwide analysis of the outcomes and mortality of hospitalized COVID-19 patients. Curr Probl Cardiol 2023; 48 (02) 101440
    CrossrefPubMedGoogle Scholar
  • 21 Isath A, Malik A, Bandyopadhyay D. et al. COVID-19, heart failure hospitalizations, and outcomes: a nationwide analysis. Curr Probl Cardiol 2023; 48 (04) 101541
    CrossrefPubMedGoogle Scholar
  • 22 Goel A, Malik AH, Bandyopadhyay D. et al. Impact of COVID-19 on outcomes of patients hospitalized with STEMI: a nationwide propensity-matched analysis. Curr Probl Cardiol 2023; 48 (04) 101547
    CrossrefPubMedGoogle Scholar
  • 23 HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality. Accessed February 3, 2023 at: https://hcup-us.ahrq.gov/nisoverview.jsp
    PubMedGoogle Scholar
  • 24 Devin J, Marano R, Mikhael M, Feaster W, Sanger T, Ehwerhemuepha L. Epidemiology of neonatal COVID-19 in the United States. Pediatrics 2022; 150 (04) e2022056297
    CrossrefPubMedGoogle Scholar
  • 25 Mullins E, Hudak ML, Banerjee J. et al; PAN-COVID investigators and the National Perinatal COVID-19 Registry Study Group. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol 2021; 57 (04) 573-581
    CrossrefPubMedGoogle Scholar
  • 26 Lakshminrusimha S, Hudak ML, Dimitriades VR, Higgins RD. Multisystem inflammatory syndrome in neonates following maternal SARS-CoV-2 COVID-19 infection. Am J Perinatol 2022; 39 (11) 1166-1171
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 García-Salido A, de Carlos Vicente JC, Belda Hofheinz S. et al; Spanish Pediatric Intensive Care Society working group on SARS-CoV-2 infection. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care 2020; 24 (01) 666
    CrossrefPubMedGoogle Scholar
  • 28 Lu X, Zhang L, Du H. et al; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med 2020; 382 (17) 1663-1665
    CrossrefPubMedGoogle Scholar
  • 29 Boyce TG, Mellen BG, Mitchel Jr EF, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000; 137 (06) 865-870
    CrossrefPubMedGoogle Scholar
  • 30 Prochaska E, Jang M, Burd I. COVID-19 in pregnancy: placental and neonatal involvement. Am J Reprod Immunol 2020; 84 (05) e13306
    CrossrefPubMedGoogle Scholar
  • 31 Abedi V, Olulana O, Avula V. et al. Racial, economic, and health inequality and COVID-19 infection in the United States. J Racial Ethn Health Disparities 2021; 8 (03) 732-742
    CrossrefPubMedGoogle Scholar
  • 32 Williamson EJ, Walker AJ, Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584 (7821) 430-436
    CrossrefPubMedGoogle Scholar
  • 33 Bailey LC, Razzaghi H, Burrows EK. et al. Assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States. JAMA Pediatr 2021; 175 (02) 176-184
    CrossrefPubMedGoogle Scholar
  • 34 Saatci D, Ranger TA, Garriga C. et al. Association between race and COVID-19 outcomes among 2.6 million children in England. JAMA Pediatr 2021; 175 (09) 928-938
    CrossrefPubMedGoogle Scholar
  • 35 Park S, Lee Y, Michelow IC, Choe YJ. Global seasonality of human coronaviruses: a systematic review. Open Forum Infect Dis 2020; 7 (11) ofaa443
    CrossrefPubMedGoogle Scholar
  • 36 Dowell SF. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg Infect Dis 2001; 7 (03) 369-374
    CrossrefPubMedGoogle Scholar